Reteplase API Manufacturers
compare suppliers & get competitive offers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Reteplase API 133652-38-7?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Reteplase. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Reteplase
- Cas Number:
- 133652-38-7
- DrugBank number:
- DB00015
- Unique Ingredient Identifier:
- DQA630RIE9
About Reteplase
Do you want to know more about Reteplase? You can find a small explanation about it here. Human tissue plasminogen activator, purified, glycosylated, 355 residues purified from CHO cells. Retavase is considered a third-generation thrombolytic agent, genetically engineered to retain and delete certain portions of human tPA. Retavase is a deletion mutein of human tPA formed by deleting various amino acids present in endogenous human tPA. Retavase contains 355 of the 527 amino acids of native human tPA (amino acids 1-3 and 176-527), and retains the activity-related kringle-2 and serine protease domains of human tPA. Three domains are deleted from retavase - kringle-1, finger, and epidermal growth factor (EGF).
Check who is selling Reteplase in the overview above.
